Ep. 366 - Europe's need for speed: Bio€quity takeaways

China’s speed in generating first-in-human data has catalyzed a race across the globe to reshape regulatory requirements to compete. BioCentury’s analysts, along with special guests Detlev Mennerich, head of Boehringer Ingelheim Venture Fund, and Mehdi Ainouche, partner at Jeito Capital, discussed where Europe fits in that landscape and other takeaways from the 26th annual Bio€quity Europe conference in Prague. This special episode of BioCentury This Week has been brought to you by Jeito Capital.View full story: https://www.biocentury.com/article/659450#EuropeanBiotech #ClinicalDevelopment #BiopharmaInnovation #DrugDevelopment #LifeSciencesStrategy00:01 - Sponsor Message: Jeito Capital 03:14 - China’s Speed Challenge04:08 - Europe’s Clinical Trial Opportunity11:48 - Speed vs. Capital Efficiency15:52 - Takeaways from Richard Pazdur19:58 - FDA Uncertainty and Global Alternatives26:50 - Biopharma M&A Outlook33:34 - The Next Wave of ScienceTo submit a question to BioCentury’s editors, email the BioCentury This Week team at [email protected] us by sending a text